Silvant Capital Management LLC decreased its position in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 29.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,775 shares of the medical device company’s stock after selling 6,145 shares during the […]
Ceredex Value Advisors LLC reduced its stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 47.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 280,985 shares of the medical device company’s stock after selling 253,066 shares during the quarter. Cooper Companies makes […]
Congress Asset Management Co. MA raised its holdings in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 321,841 shares of the medical device company’s stock after […]
Cooper Companies (NYSE:COO – Get Rating) had its price objective lowered by investment analysts at KeyCorp from $459.00 to $414.00 in a note issued to investors on Wednesday, The Fly reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. KeyCorp’s price target suggests a potential upside of 21.39% from the […]
Wall Street brokerages expect The Cooper Companies, Inc. (NYSE:COO – Get Rating) to announce $3.45 earnings per share for the current quarter, Zacks reports. Seven analysts have made estimates for Cooper Companies’ earnings, with estimates ranging from $3.41 to $3.51. Cooper Companies posted earnings of $3.38 per share during the same quarter last year, which […]